Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Leukotriene B4

Prostanoid receptor ligand
 
BML-LB004-0050 50 µg 275.00 USD
 
BML-LB004-1000 1 mg 3,635.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-340-038

Activator of PPARα. Stimulates leukocyte functions including chemokinesis, chemotaxis, lysosomal enzyme release, adhesion, stimulation of ion fluxes, superoxyde anion production and C3b receptor expression. Induces vascular permeability, NK cell activity, and broncho-constriction. UVmax: 270 nm (50,000).

Product Specification

Alternative Name:LTB4, 5,12-Dihydroxy-[S-[R*,S*-(E,Z,Z,E)]]-6,8,10,14-eicosatetraenoic acid
 
Formula:C20H32O4
 
MW:336.5
 
Source:Synthetic.
 
CAS:71160-24-2
 
MI:14: 5455
 
Concentration:50 µg size: 50 µg/ml
1 mg size: 1 mg/ml
 
Formulation:Oil dissolved in ethanol.
 
Purity:≥99% (HPLC)
 
Appearance:Colorless liquid.
 
Shipping:Shipped on Dry Ice
 
Long Term Storage:-80°C
 
Use/Stability:Stable for at least 1 year after receipt when stored, as supplied, at -80°C.
 
Handling:Open ampule and aliquot into suitable tubes or vials. Store at -80°C or colder. For experiments with cells or tissues, aliquots of ethanol solutions may be added directly to aqueous media. For HPLC, aliquots of ethanol solutions should be evaporated to dryness under a stream of nitrogen and HPLC mobile phase added to the desired concentration.
 
bml-lb004
Please mouse over
bml-lb004

Product Literature References

Ligand selectivity of the peroxisome proliferator-activated receptor alpha: Q. Lin et al.; Biochemistry 38, 185 (1999), Abstract;
Leukotriene B4: S.W. Crooks & R.A. Stockley; nt. J. Biochem. Cell Biol. 30, 173 (1998), Abstract;
The peroxisome proliferator-activated receptor alpha (PPARalpha) ligand WY 14,643 does not interfere with leukotriene B4 induced adhesion of neutrophils to endothelial cells: M. Heimburger & J. Palmblad; Biochem. Biophys. Res. Commun. 249, 371 (1998), Abstract;
The PPARalpha-leukotriene B4 pathway to inflammation control: P.R. Devchand et al.; Nature 384, 39 (1996), Abstract;
Biosynthesis and biological activity of leukotriene B4: P. Borgeat & P.H. Naccache; Clin. Biochem. 23, 459 (1990), Abstract;
Leukotriene B4 in inflammation: A.W. Ford-Hutchinson; Crit. Rev. Immunol. 10, 1 (1990), Abstract;
Leukotrienes and inflammation: S.D. Brain & T.J. Williams; Pharmacol. Ther. 46, 57 (1990), Abstract;
Quantitative gas chromatography-mass spectrometry analysis of leukotriene B4: W.R. Mathews; Methods Enzymol. 187, 76 (1990), Abstract;
Leukotrienes and the immune system: M. Rola-Pleszczynski; J. Lipid Mediat. 1, 149 (1989), Abstract;
Leukotriene B4 and inflammatory disease: R.M. McMillan & S.J. Foster; Agents Actions 24, 114 (1988), Abstract;
Molecular and cellular properties of human polymorphonuclear leukocyte receptors for leukotriene B4: D.W. Goldman et al.; Fed. Proc. 46, 200 (1987), Abstract;
Solid-phase extraction and high-performance liquid chromatography analysis of lipoxygenase pathway products: J.D. Eskra et al.; Anal. Biochem. 154, 332 (1986), Abstract;
The combined use of isolated strips of guinea-pig lung parenchyma and ileum as a sensitive and selective bioassay for leukotriene B4: M.N. Samhoun & P.J. Piper; Prostaglandins 27, 711 (1984), Abstract;

Related Products

Leukotriene B4 & ω oxidation metabolites mixture 

≥90% (HPLC) | Print as PDF
 
BML-SM115-0001 1 Ampoule 207.00 USD
Do you need bulk/larger quantities?
 

Related Literature

Catalogs
Diabetes Catalog
Diabetes Catalog
Download as PDF

Technical Posters
Arachidonic Acid Metabolites
Arachidonic Acid Metabolites
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,